[
Larimar Therapeutics CEO Carole Ben-Maimon buys $49,953 in stock.
[og_img]
https://www.investing.com/news/insider-trading-news/larimar-therapeutics-ceo-carole-benmaimon-buys-49953-in-stock-93CH-5029351
Investing.com
Larimar Therapeutics CEO Carole Ben-Maimon buys $49,953 in stock.
Related articles




